Pneumonia guidelines in practice

Antibiotic Policies: Theory and Practice

Volumn , Issue , 2005, Pages 37-66

  Barlow, Gavin ^a  

^a NHS TAYSIDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45749106486     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-22852-7_4     Document Type: Chapter

References (81)

1. American College of Physicians-American Society of Internal Medicine, 1999, Compendium of primers. A primer on before-after studies: Evaluating a report of a "successful" intervention. Effect. Clin. Pract., 2, 5-6.
2. American Thoracic Society, 2001, Guidelines for the management of adults with community-acquired pneumonia. Am. J. Respir. Crit. Care Med., 163, 1730-1754.
3. Al-Eidan, F. A., McElnay, J. C, Scott, M. G., Kearney, M. P., Corrigan, J., and McConnell, J. B., 2000, Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. J. Antimicrob. Chemother., 45, 387-394.
4. Angus, D. C, Marrie, T. J., Obrosky, D. S., Clermont, G, Dremsizov, T. T., Coley, C. et al., 2002, Severe community-acquired pneumonia: Use of intensive care services and evaluation of American and British Thoracic Society diagnostic criteria. Am. J. Resp. Crit. Care Med., 166, 717-723.
5. Atlas, S. J., Benzer, T. I., Borowsky, L. H., Chang, Y., Burnham, D. C, Metlay, J. P. et al., 1998, Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: An interventional trial. Arch. Intern. Med., 158, 1350-1356.
6. Bartlett, J. G, Breiman, R. F, Mandell, L. A., and File, T. M. Jr, 1998, Community-acquired pneumonia in adults: guidelines for management. Infectious Diseases Society of America. Clin. Infect. Dis., 26, 811-838.
7. Bartlett, J. G, Dowell, S. F, Mandell, L. A., File, T. M. Jr, Musher, D. M., and Fine, M. J., 2000, Practice guidelines for the management of community-acquired pneumonia in adults. Clin. Infect. Dis., 31, 347-382.
8. Battleman, D. S., Callaghan, M., and Thaler, H. T., 2002, Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia. Arch. Intern. Med., 162, 682-688.
9. Bero, L. A., Grilli, R., Grimshaw, J. M., Harvey, E., Oxman, A. D., and Thompson, M. A., 1998, Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. BMJ, 317, 465-468.
10. Benenson, R., Magalski, A., Cavanaugh, S., and Williams, E., 1999, Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality. Acad. Emerg. Med., 6, 1243-1248.
11. Bloor, K., Freemantle, N., Khadjesari, Z., and Maynard, A., 2003, Impact of NICE guidance on laparoscopic surgery for inguinal hernias: Analysis of interrupted time series. BMJ, 326, 578.
12. British Thoracic Society, 1993, British Thoracic Society guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br. J. Hosp. Med., 49, 346-350.
13. British Thoracic Society, 2001, BTS guidelines for the management of community-acquired pneumonia in adults. Thorax, 56(Suppl. 4), 1-64.
14. Bryan, F., 1981, Hazard analysis critical control point approach: epidemiological rationale and application to foodservice operations. J. Environ. Health, 44, 7-14.
15. Cabana, M. D., Rand, C. S., Powe, N. R, Wu, A. W., Wilson, M. H, and Abboud, P.-A. C, 1999, Why don't physicians follow clinical practice guidelines. A framework for improvement. JAMA, 282, 1458-1465.
16. Campbell, S. M., Braspenning, J., Hutchinson, A., and Marshall, M. N., 2003, Research methods used in developing and applying quality indicators in primary care. BMJ, 326, 816-819.
17. Castro-Guardiola, A., Viejo-Rodríguez, A.-L., Soler-Simon, S., Armengou-Arxé, A., Bisbe-Company, V, Peñarroja-Matutano et al., 2001, Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: A randomised controlled trial. Am. J. Med., 111, 367-374.
18. Chu, L. A., Bratzler, D. W, Lewis, R. J., Murray, C, Moore, L., Shook, C. et al., 2003, Improving the quality of care for patients with pneumonia in very small hospitals. Arch. Intern. Med., 163, 326-332.
19. Crombie, I. K. and Davies, H. T. O., 1998, Beyond health outcomes: the advantages of measuring process. J. Eval. Clin. Pract., 4, 31-38.
20. Dean, N. C, Silver, M. P., Bateman, K. A., Brent, J., Hadlock, C. J., and Hale, D., 2001, Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am. J. Med., 110, 451-457.
21. Dean, N. C, Suchyta, M. R, Bateman, K. A., Aronsky, D, and Hadlock, C. J., 2000, Implementation of admission decision support for community-acquired pneumonia. A pilot study. Chest, 117, 1368-1377.
22. Dobbin, C. J., Duggan, C. J., and Barnes, D. J., 2001, The efficacy of an antibiotic protocol for community-acquired pneumonia. MJA, 174, 333-337.
23. Dowell, J., Huby, G, and Smith, C, 1995, Scottish Consensus Statement on Qualitative Research in Primary Health Care. Tayside Centre for General Practice, University of Dundee, Dundee, UK.
24. Ewig, S., Ruiz, M., Mensa, J., Marcos, M. A., Martinez, J. A., Arancibia, F. et al., 1998, Severe community-acquired pneumonia: assessment of severity criteria. Am. J. Respir Crit. Care Med., 158, 1102-1108.
25. File, T. M. Jr, Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R R et al., 1997, A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob. Agents Chemother., 41, 1965-1972.
26. Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E. et al., 1997, A prediction rule to identify low risk patients with community-acquired pneumonia. N. Engl. J. Med., 336, 243-250.
27. Florida Medical Quality Assurance, Inc., 1998, Quality of care improvements for patients with pneumonia. Eval. Health Prof., 21, 514-524.
28. Fortune, G., Elder, S., Jaco, D., Bentivegna, P., Luebbering, T., and Boechler, M., 1996, Opportunities for improving the care of patients with community-acquired pneumonia. Clin. Perform. Qual. Health Care, 4, 41-43.
29. Gleason, P. P., Kapoor, W. N., Stone, R A., Lave, J. R, Obrosky, D. S., Schulz, R. et al., 1997, Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA, 278, 32-39.
30. Goddard, M., Davies, H. T. O., Dawson, D, Mannion, R, and McInnes, F., 2002, Clinical performance measurement: Part 1-getting the best out of it. J. R. Soc. Med., 95, 508-510.
31. Gordon, G S., Throop, D., Berberian, L., Niederman, M., Bass, J., Ale-Mayehu, D., et al., 1996, Validation of the therapeutic recommendations of the American Thoracic Society (ATS) guidelines for community acquired pneumonia in hospitalized patients. Chest, 110, 55S.
32. Gottlieb, L. D., Roer, D., Jega, K., D'arc, St. Pierre, J., Dobbins, J., Dwyer, M. et al., 1996, Clinical pathway for pneumonia: Development, implementation, and initial experience. Best Pract. Benchmarking Healthc., 1, 262-265.
33. Greenhalgh, T. (ed.), 2001, Papers that go beyond numbers (qualitative research). In How to Read a Paper, Chapter 11. BMJ Publishing Group, London, UK.
34. Guest, J. F. and Morris, A., 1997, Community-acquired pneumonia: The annual cost to the National Health Service in the United Kingdom. Eur Respir J., 10, 1530-1534.
35. Halley, H. J., 2000, Approaches to drug therapy, formulary, and pathway management in a large community hospital. Am. J. Health Syst. Pharm., 57(Suppl. 3), S17-S21.
36. Halm, E. A., Atlas, S. J., Borowsky, L. H, Benzer, T. I., Metlay, J. P., Chang, Y. C. et al., 2000, Understanding physician adherence with a pneumonia practice guideline. Effects of patient, system and physician factors. Arch. Intern. Med., 160, 98-104.
37. Halm, E. A., Fine, M. J., Kapoor, W. N., Singer, D. E., Marrie, T. J., and Siu, A. L., 2002, Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch. Intern. Med., 162, 1278-1284.
38. Hill, A. B., 1965, The environment and disease: Association or causation? Proc. R. Soc. Med., 58, 295-300.
39. Lamping, D L., Schroter, S., Marquis, P., Marrel, A., Duprat-Lomon, I., Sagnier, P.-P., 2002, The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest, 122, 920-929.
40. Lawrence, S. J., Shadel, B. N., Leet, T. L., Hall, J. B., and Mundy, L. M., 2002, An intervention to improve antibiotic delivery and sputum procurement in patients hospitalised with community-acquired pneumonia. Chest, 122, 913-919.
41. Lim, W. S., Macfarlane, J. T, Boswell, T. C. J., Harrison, T. G, Rose, D, Leinonen, M. et al., 2001, Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax, 56, 296-301.
42. Macdonald, J. D. and Engel, D., 1996, A Guide to HACCP Hazard Analysis for Small Businesses. Highfield Publications, Goncaster.
43. Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., Hyland, R. H., and the Canadian Community-Acquired Pneumonia Working Group, 2000, Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin. Infect. Dis., 31, 383-421.
44. Mandell, L. A. and Niederman, M., 1993, Antimicrobial treatment of community-acquired pneumonia in adults: A conference report. Canadian Community-Acquired Pneumonia Consensus Conference Group. Can. J. Infect. Dis., 4, 25.
45. Mant, J. and Hicks, N, 1995, Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ, 311, 793-796.
46. Marrie, T. J., Lau, C. Y., Wheeler, S. L., Wong, C. J., Vandervoort, M. K., and Feagan, B. G, 2000, A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA, 283, 749-755.
47. McCormick, D., Fine, M. J., Coley, C. M., Marrie, T. J., Lave, J. R, Obrosky, D. S. et al., 1999, Variation in length of hospital stay in patients with community-acquired pneumonia: Are shorter stays associated with worse medical outcomes? Am. J. Med., 107, 5-12.
48. McGarvey, R. N. and Harper, J. J., 1993, Pneumonia mortality reduction and quality improvement in a community hospital. QRB Qual. Rev. Bull., 19, 124-130.
49. Meehan, T. P., Fine, M. J., Krumholz, H. M., Scinto, J. D, Galush, D H., Mockalis, J. T. et al., 1997, Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA, 278, 2080-2084.
50. Meehan, T. P., Weingarten, S. R, Holmboe, E. S., Mathur, D., Wang, Y., Petrillo, M. K. et al., 2001, A statewide initiative to improve the care of hospitalised pneumonia patients: The Connecticut pneumonia pathway project. Am. J. Med., 111, 203-210.
51. Menendez, R., Ferrando, D, Valles, J. M., and Vallterra, J., 2002, Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest, 122, 612-617.
52. Metersky, M. L., Tate, J. P., Fine, M. J., Petrillo, M. K., and Meehan, T. P., 2000, Temporal trends in outcomes of older patients with pneumonia. Arch. Intern. Med., 160, 3385-3391.
53. Mortenson, E. M., Coley, C. M., Singer, D. E., Marrie, T. M., Obrosky, D. S., Kapoor, W N. et al., 2002, Causes of death for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch. Intern. Med., 162, 1059-1064.
54. National Pathways Association, 2001, Developing care pathways. In K. du Lac (ed.), The Handbook. Radcliffe Medical Press, Abingdon, Oxon, UK.
55. Niederman, M. S., Bass, J. B. Jr, Campbell, G D, Fein, A. M., Grossman, R. F, Mandell, L. A. et al., 1993, Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Am. Rev. Respir Dis., 148, 1418-1426.
56. Niederman, M. S., McCombs, J. S., Unger, A. N, Kumar, A., and Popovian, R., 1998, The cost of treating community-acquired pneumonia. Clin. Ther, 20, 820-837.
57. Øvretveit, J. and Gustafson, D., 2003, Using research to inform quality programmes. BMJ, 326, 759-761.
58. Paladino, J. A., Gudgel, L. D, Forrest, A., and Niederman, M. S., 2002, Cost-effectiveness of IV-oral switch therapy: Azithromycin versus cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia. Chest, 122, 1271-1279.
59. Pallares, R., Linares, J., Vadillo, M., Cabellos, C, Manresa, F., Viladrich, P. F. et al., 1995, Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med., 333, 474-480.
60. Palmer, C. S., Zhan, C, Elixhauser, A., Halpern, M. T., Rance, L., Feagan, B. G. et al., 2000, Economic assessment of the community-acquired pneumonia intervention trail employing levofloxacin. Clin. Ther., 22, 250-264.
61. Pearson, S. D., Goulart-Fisher, D., and Lee, T. H. 1995, Critical pathways as a strategy for improving care: Problems and potential. Ann. Intern. Med. 123, 941-948.
62. Phillips, K. F. and Crain, H. C, 1998, Effectiveness of a pneumonia clinical pathway: Quality and financial outcomes. Outcomes Manag. Nurs. Pract., 2, 16-22.
63. Pope, C. and Mays, N., 2000, Qualitative research in health care: Assessing quality in qualitative research. BMJ, 320, 50-52.
64. Pope, C, Ziebland, S., and Mays, N., 2000, Qualitative research in health care: Analyzing qualitative data. BMJ, 320, 114-116.
65. Ramos, K. D., Schafer, S., and Tracz, S. M., 2003, Validation of the Fresno test of competence in evidence based medicine. BMJ, 326, 319-321.
66. Reddy, J. C, Katz, Goldman, L., and Wachter, R. M., 2001, A pneumonia practice guideline and a hospitalist-based reorganization lead to equivalent efficiency gains. Am. J. Manag. Care, 7, 1142-1148.
67. Rhew, D. C., Riedinger, M. S., Sandhu, M., Bowers, C., Greengold, N., and Weingarten, S. R., 1998, A prospective, multicenter study of a pneumonia practice guideline. Chest, 114, 115-119.
68. Rhew, D. C., Tu, G S., Ofman, J., Henning, J. M., Richards, M. S., and Weingarten, S. R., 2001, Early switch and early discharge strategies in patients with community-acquired pneumonia: A meta-analysis. Arch. Intern. Med., 161, 722-727.
69. Rollins, D., Thomasson, C, and Sperry, B., 1994, Improving antibiotic delivery to pneumonia patients: Continuous quality improvement in action. J. Nurs. Care Qual., 8, 22-31.
70. Ross, G, Johnson, D., Kobernick, M., and Pokriefka, R, 1997, Evaluation of a critical care pathway for pneumonia. J. Healthc. Qual, 22-29, 36.
71. Sanyal, S., Smith, P. R, Saha, A. C, Gupta, S., Berkowitz, L., and Homel, P., 1999, Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am. J. Respir Crit. Care Med., 160, 346-348.
72. Solomon, D. H., Van Houten, L. V, Glynn, R J., Baden, L., Curtis, K., Schrager, H. et al., 2001, Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch. Intern. Med., 161, 1897-1902.
73. Sperry, S. and Birdsall, C, 1994, Outcomes of a pneumonia critical path. Nurs. Econ., 12, 332-339, 345.
74. Stahl, J. E., Barza, M., DesJardin, J., Martin, R., and Eckham, M. H., 1999, Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch. Intern. Med., 159, 2511-2512.
75. Suchyta, M. R., Dean, N. C, Narus, S., and Hadlock, C. J., 2001, Effects of a practice guideline for community-acquired pneumonia in an outpatient setting. Am. J. Med., 110, 306-309.
76. Tunis, S. R., Hayward R. S. A., Wilson, M. C, Rubin, H. R., Bass, E. B., Johnston, M. et al., 1994, Internists' attitudes about clinical practice guidelines. Ann. Intern. Med., 120, 956-963.
77. Waterer, G W, Somes, G W, and Wunderrink, R. G, 2001, Monotherapy may be sub-optimal for severe bacteraemic pneumococcal pneumonia. Arch. Intern. Med., 161, 1837-1842.
78. Wagner, A. K., Soumerai, S. B., Zhang, F., and Ross-Degnan, D., 2002, Segmented regression analysis of interrupted time series studies in medication use research. J. Clin. Pharm. Ther, 27, 299-309.
79. Wensing, M. and Elwyn, G., 2003, Methods for incorporating patients' views in health care. BMJ, 326, 877-879.
80. Weingarten, S. R., Riedinger, M. S., Hobson, P., Noah, M. S., Johnson, B., Giugliano, G. et al., 1996, Evaluation of a pneumonia practice guideline in an interventional trial. Am. J. Resp. Crit. Care Med., 153, 1110-1115.
81. World Health Organisation, 1947, The constitution of the World Health Organisation. WHO Chronicles, 1, 29.